EVALUATION OF INVASIVE ORAL PROCEDURES AND EVENTS (OPES) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) TREATED FOR UP TO 10 YEARS WITH DENOSUMAB (DMAB): RESULTS FROM THE PHASE 3 FREEDOM OPEN-LABEL EXTENSION (EXT)
OSTEOPOROSIS INTERNATIONAL（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要